Skip to main content
. 2016 Nov 1;55(21):3151–3153. doi: 10.2169/internalmedicine.55.6738

Figure 3.

Figure 3.

A chest CT scan and brain MRI before and during treatment with crizotinib (A and C: May 2015, B and D: Aug 2015). Crizotinib reduced the primary mass (arrows) from 26 mm (A) to 15 mm (B), and the multiple lung metastases (arrowheads) disappeared. Crizotinib also reduced the brain metastasis (arrows) from 13.3 mm (C) to 6.2 mm (D).